STERIS plc (NYSE: STE) Stock Competitors & Peer Comparison

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, ALC has a market cap of 32.5B. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while ALC trades at $66.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas ALC's P/E ratio is 20.93. In terms of profitability, STE's ROE is +0.11%, compared to ALC's ROE of +0.03%. Regarding short-term risk, STE is less volatile compared to ALC. This indicates lower risk in terms of short-term price fluctuations for STE.Check ALC's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, QDEL has a market cap of 828.5M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while QDEL trades at $12.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas QDEL's P/E ratio is 9.07. In terms of profitability, STE's ROE is +0.11%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, STE is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for STE.Check QDEL's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, MLAB has a market cap of 676.6M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while MLAB trades at $120.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas MLAB's P/E ratio is 12.20. In terms of profitability, STE's ROE is +0.11%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, STE is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for STE.Check MLAB's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, BWAY has a market cap of 545.6M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while BWAY trades at $13.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas BWAY's P/E ratio is 35.34. In terms of profitability, STE's ROE is +0.11%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, STE is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for STE.Check BWAY's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, SI has a market cap of 396.1M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while SI trades at $19.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas SI's P/E ratio is -11.04. In terms of profitability, STE's ROE is +0.11%, compared to SI's ROE of -0.26%. Regarding short-term risk, STE is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for STE.Check SI's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, MASS has a market cap of 383.6M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while MASS trades at $9.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas MASS's P/E ratio is -15.58. In terms of profitability, STE's ROE is +0.11%, compared to MASS's ROE of -0.25%. Regarding short-term risk, STE is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for STE.Check MASS's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, MOBI has a market cap of 340.8M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while MOBI trades at $10.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas MOBI's P/E ratio is -0.55. In terms of profitability, STE's ROE is +0.11%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, STE is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for STE.Check MOBI's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, LAB has a market cap of 284.6M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while LAB trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas LAB's P/E ratio is -10.39. In terms of profitability, STE's ROE is +0.11%, compared to LAB's ROE of -0.18%. Regarding short-term risk, STE is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for STE.Check LAB's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, ANIK has a market cap of 280.9M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while ANIK trades at $20.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas ANIK's P/E ratio is 42.84. In terms of profitability, STE's ROE is +0.11%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, STE is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for STE.Check ANIK's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while EDAP trades at $4.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas EDAP's P/E ratio is -5.80. In terms of profitability, STE's ROE is +0.11%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, STE is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for STE.Check EDAP's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, TRIB has a market cap of 157.8M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while TRIB trades at $7.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas TRIB's P/E ratio is -0.13. In terms of profitability, STE's ROE is +0.11%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, STE is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for STE.Check TRIB's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, NYXH has a market cap of 150.1M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while NYXH trades at $1.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas NYXH's P/E ratio is -0.60. In terms of profitability, STE's ROE is +0.11%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, STE is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for STE.Check NYXH's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, APYX has a market cap of 121.7M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while APYX trades at $2.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas APYX's P/E ratio is -14.45. In terms of profitability, STE's ROE is +0.11%, compared to APYX's ROE of -0.79%. Regarding short-term risk, STE is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for STE.Check APYX's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, SKIN has a market cap of 89.4M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while SKIN trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas SKIN's P/E ratio is -3.14. In terms of profitability, STE's ROE is +0.11%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, STE is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for STE.Check SKIN's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, MDAI has a market cap of 49.6M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while MDAI trades at $1.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas MDAI's P/E ratio is -3.47. In terms of profitability, STE's ROE is +0.11%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, STE is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for STE.Check MDAI's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, DRIO has a market cap of 48.7M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while DRIO trades at $6.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas DRIO's P/E ratio is -1.14. In terms of profitability, STE's ROE is +0.11%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, STE is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for STE.Check DRIO's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, BEAT has a market cap of 22.8M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while BEAT trades at $0.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas BEAT's P/E ratio is -0.80. In terms of profitability, STE's ROE is +0.11%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, STE is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for STE.Check BEAT's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, BEATW has a market cap of 8.6M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while BEATW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas BEATW's P/E ratio is -0.02. In terms of profitability, STE's ROE is +0.11%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, STE is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for STE.Check BEATW's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, WOK has a market cap of 4.8M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while WOK trades at $1.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas WOK's P/E ratio is N/A. In terms of profitability, STE's ROE is +0.11%, compared to WOK's ROE of -0.19%. Regarding short-term risk, STE is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for STE.Check WOK's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while QTEXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, STE's ROE is +0.11%, compared to QTEXW's ROE of N/A. Regarding short-term risk, STE is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for STE.Check QTEXW's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, ITOC has a market cap of 2.9M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while ITOC trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas ITOC's P/E ratio is -0.98. In terms of profitability, STE's ROE is +0.11%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, STE is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for STE.Check ITOC's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, FEED has a market cap of 2.8M. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while FEED trades at $3.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas FEED's P/E ratio is -0.03. In terms of profitability, STE's ROE is +0.11%, compared to FEED's ROE of -0.60%. Regarding short-term risk, STE is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for STE.Check FEED's competition here

STERIS plc (NYSE: STE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STE stands at 20.7B. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, STE is priced at $212.45 on the NYSE, while TIVC trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STE currently has a P/E ratio of 20.39, whereas TIVC's P/E ratio is -0.04. In terms of profitability, STE's ROE is +0.11%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, STE is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for STE.Check TIVC's competition here